Scientists are convinced combining navitoclax with ruxolitinib should help individuals with myelofibrosis. With this trial half the individuals have navitoclax and ruxolitinib. The other 50 % have ruxolitinib plus a dummy drug (placebo ). Skip to main information Thank you for traveling to mother nature.com. You happen to be employing https://wayloncpbm676543.jts-blog.com/25785830/fascination-about-olorofim